HIV - recentes avanços na pesquisa de fármacos

Detalhes bibliográficos
Autor(a) principal: Cunico,Wilson
Data de Publicação: 2008
Outros Autores: Gomes,Claudia R. B., Vellasco Junior,Walcimar T.
Tipo de documento: Artigo
Idioma: por
Título da fonte: Química Nova (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422008000800035
Resumo: The development of new antiretroviral drugs is a dynamic process that is continuously fueled by identification of new molecular targets and new compounds for know targets. The current available drugs can be classified into five categories: nucleoside analogues reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors and entry inhibitors (fusion inhibitors and CCR5 antagonist). In addition, the maturation inhibitors may be considered as potential target for chemotherapeutic intervention. This review presents some anti-HIV agents that have already gone through the advance development process for final approval for the treatment of AIDS.
id SBQ-3_eab0469c553296fb7a28f8de12bb5f0c
oai_identifier_str oai:scielo:S0100-40422008000800035
network_acronym_str SBQ-3
network_name_str Química Nova (Online)
repository_id_str
spelling HIV - recentes avanços na pesquisa de fármacosanti-HIV drugsAIDSnew drugsThe development of new antiretroviral drugs is a dynamic process that is continuously fueled by identification of new molecular targets and new compounds for know targets. The current available drugs can be classified into five categories: nucleoside analogues reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors and entry inhibitors (fusion inhibitors and CCR5 antagonist). In addition, the maturation inhibitors may be considered as potential target for chemotherapeutic intervention. This review presents some anti-HIV agents that have already gone through the advance development process for final approval for the treatment of AIDS.Sociedade Brasileira de Química2008-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422008000800035Química Nova v.31 n.8 2008reponame:Química Nova (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0100-40422008000800035info:eu-repo/semantics/openAccessCunico,WilsonGomes,Claudia R. B.Vellasco Junior,Walcimar T.por2009-01-16T00:00:00Zoai:scielo:S0100-40422008000800035Revistahttps://www.scielo.br/j/qn/ONGhttps://old.scielo.br/oai/scielo-oai.phpquimicanova@sbq.org.br1678-70640100-4042opendoar:2009-01-16T00:00Química Nova (Online) - Sociedade Brasileira de Química (SBQ)false
dc.title.none.fl_str_mv HIV - recentes avanços na pesquisa de fármacos
title HIV - recentes avanços na pesquisa de fármacos
spellingShingle HIV - recentes avanços na pesquisa de fármacos
Cunico,Wilson
anti-HIV drugs
AIDS
new drugs
title_short HIV - recentes avanços na pesquisa de fármacos
title_full HIV - recentes avanços na pesquisa de fármacos
title_fullStr HIV - recentes avanços na pesquisa de fármacos
title_full_unstemmed HIV - recentes avanços na pesquisa de fármacos
title_sort HIV - recentes avanços na pesquisa de fármacos
author Cunico,Wilson
author_facet Cunico,Wilson
Gomes,Claudia R. B.
Vellasco Junior,Walcimar T.
author_role author
author2 Gomes,Claudia R. B.
Vellasco Junior,Walcimar T.
author2_role author
author
dc.contributor.author.fl_str_mv Cunico,Wilson
Gomes,Claudia R. B.
Vellasco Junior,Walcimar T.
dc.subject.por.fl_str_mv anti-HIV drugs
AIDS
new drugs
topic anti-HIV drugs
AIDS
new drugs
description The development of new antiretroviral drugs is a dynamic process that is continuously fueled by identification of new molecular targets and new compounds for know targets. The current available drugs can be classified into five categories: nucleoside analogues reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors and entry inhibitors (fusion inhibitors and CCR5 antagonist). In addition, the maturation inhibitors may be considered as potential target for chemotherapeutic intervention. This review presents some anti-HIV agents that have already gone through the advance development process for final approval for the treatment of AIDS.
publishDate 2008
dc.date.none.fl_str_mv 2008-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422008000800035
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422008000800035
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 10.1590/S0100-40422008000800035
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Química
publisher.none.fl_str_mv Sociedade Brasileira de Química
dc.source.none.fl_str_mv Química Nova v.31 n.8 2008
reponame:Química Nova (Online)
instname:Sociedade Brasileira de Química (SBQ)
instacron:SBQ
instname_str Sociedade Brasileira de Química (SBQ)
instacron_str SBQ
institution SBQ
reponame_str Química Nova (Online)
collection Química Nova (Online)
repository.name.fl_str_mv Química Nova (Online) - Sociedade Brasileira de Química (SBQ)
repository.mail.fl_str_mv quimicanova@sbq.org.br
_version_ 1750318108374990848

Registros relacionados